Heres Why You Should Retain Neogen Stock for Now
NEOG Stock | USD 12.04 0.02 0.17% |
Roughly 62% of all Neogen's stockholders are looking to take a long position. The analysis of overall sentiment of trading Neogen stock suggests that some investors are interested at this time. The current market sentiment, together with Neogen's historical and current headlines, can help investors time the market. In addition, many technical investors use Neogen stock news signals to limit their universe of possible portfolio assets.
Neogen |
Investors are optimistic about Neogen on strong growth in Animal and Food Safety businesses.
Read at zacks.com
Neogen Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Neogen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Neogen Fundamental Analysis
We analyze Neogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Neogen is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Neogen Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neogen stock to make a market-neutral strategy. Peer analysis of Neogen could also be used in its relative valuation, which is a method of valuing Neogen by comparing valuation metrics with similar companies.
Peers
Neogen Related Equities
XGN | Exagen | 9.34 | ||||
SERA | Sera Prognostics | 7.33 | ||||
BNR | Burning Rock | 6.99 | ||||
IQV | IQVIA Holdings | 3.00 | ||||
RDNT | RadNet | 1.85 | ||||
ICLR | ICON PLC | 1.42 | ||||
MYGN | Myriad Genetics | 0.83 | ||||
QGEN | Qiagen NV | 0.79 | ||||
MEDP | Medpace Holdings | 0.64 | ||||
FONR | Fonar | 0.20 | ||||
SHC | Sotera Health | 0.23 | ||||
ACRS | Aclaris Therapeutics | 11.69 |
Complementary Tools for Neogen Stock analysis
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |